Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients.
Argyriou AA, Velasco R, Briani C, Cavaletti G, Bruna J, Alberti P, Cacciavillani M, Lonardi S, Santos C, Cortinovis D, Cazzaniga M, Kalofonos HP. Argyriou AA, et al. Among authors: santos c. Ann Oncol. 2012 Dec;23(12):3116-3122. doi: 10.1093/annonc/mds208. Epub 2012 Aug 2. Ann Oncol. 2012. PMID: 22865779 Free article. Clinical Trial.
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients.
Velasco R, Bruna J, Briani C, Argyriou AA, Cavaletti G, Alberti P, Frigeni B, Cacciavillani M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Kalofonos HP. Velasco R, et al. Among authors: santos c. J Neurol Neurosurg Psychiatry. 2014 Apr;85(4):392-8. doi: 10.1136/jnnp-2013-305334. Epub 2013 Jun 29. J Neurol Neurosurg Psychiatry. 2014. PMID: 23813745 Clinical Trial.
Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.
Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C, Bruna J, Terrazzino S, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Psaromyalou A, Angelopoulou A, Kalofonos HP. Argyriou AA, et al. Among authors: santos c. Cancer. 2013 Oct 1;119(19):3570-7. doi: 10.1002/cncr.28234. Epub 2013 Jul 2. Cancer. 2013. PMID: 23821303 Free article.
Intrinsic cancer subtypes--next steps into personalized medicine.
Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R. Santos C, et al. Cell Oncol (Dordr). 2015 Feb;38(1):3-16. doi: 10.1007/s13402-014-0203-7. Epub 2015 Jan 14. Cell Oncol (Dordr). 2015. PMID: 25586691 Review.
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.
Terrazzino S, Argyriou AA, Cargnin S, Antonacopoulou AG, Briani C, Bruna J, Velasco R, Alberti P, Campagnolo M, Lonardi S, Cortinovis D, Cazzaniga M, Santos C, Kalofonos HP, Canonico PL, Genazzani AA, Cavaletti G. Terrazzino S, et al. Among authors: santos c. J Peripher Nerv Syst. 2015 Mar;20(1):15-23. doi: 10.1111/jns.12110. J Peripher Nerv Syst. 2015. PMID: 25858589
Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer.
García M, Martinez-Villacampa M, Santos C, Navarro V, Teule A, Losa F, Pisa A, Cambray M, Soler G, Lema L, Kreisler E, Figueras A, Juan XS, Viñals F, Biondo S, Salazar R. García M, et al. Among authors: santos c. BMC Cancer. 2015 Feb 26;15:59. doi: 10.1186/s12885-015-1052-0. BMC Cancer. 2015. PMID: 25886275 Free PMC article. Clinical Trial.
6,108 results